Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 13, 2020
Webinar
Strafford Publications
As part of Strafford Publications’ webinar series, Finnegan partners Mark Feldstein and David Weingarten will provide essential updates on FDA practice and patent law relating to biologics and biosimilars. The panel will discuss the current state of and recent changes to FDA initiatives, approvals, and exclusivities, as well as patent prosecution, post-grant proceedings, and litigation. For more information, or to register, please see Strafford Publications’ website.
